Article Text

PDF

Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.
  1. N A Buckell,
  2. S R Gould,
  3. D W Day,
  4. J E Lennard-Jones,
  5. A M Edwards

    Abstract

    Oral disodium cromoglycate (200 mg qds) has been tested in 26 patients with ulcerative colitis that was resistant to medical treatment. In a double-blind crossover trial disodium cromoglycate and placebo were added to conventional treatment in random order, each for four weeks. There was no significant difference in therapeutic effect between disodium cromoglycate and placebo.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.